First ever treatment for previously untreated late-stage Hodgkin lymphoma given NICE approval

Getty/busracavus

By Sarah Lowden

A new treatment has been given approval for routine NHS use in England and Wales for previously untreated late-stage classical Hodgkin lymphoma.

Brentuximab vedotin (brand name Adcetris) has been recommended in combination with other therapies by the National Institute for Health and Care Excellence.